Il-6 activity inhibitor
First Claim
Patent Images
1. A nucleotide sequence which inhibits IL-6 activity, that comprises:
- i) at least one nucleotide sequence that is an APRE element of general formula ZXMYKGKAA, wherein Z represents T or G or can also be absent, X represents T or can also be absent, M represents C or A, Y represents C or T and K represents T or G;
ii) at least one nucleotide sequence constituting a transcription factor binding site other than the APRE element.
6 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a nucleotide sequence, which is able to inhibit the IL-6 activity, its use in therapy as well as pharmaceutical compositions containing it.
In particular, it relates to a nucleotide sequence which comprises:
i) at least one nucleotide sequence that is an APRE element of general formula ZXMYKGKAA, wherein Z represents T or G or can also be absent, X represents T or can also be absent, M represents C or A, Y represents C or T and K represents T or G,
in conjunction with
ii) at least one nucleotide sequence constituting a transcription factor binding site other than the APRE element, such as those present in promoter regions.
56 Citations
14 Claims
-
1. A nucleotide sequence which inhibits IL-6 activity, that comprises:
-
i) at least one nucleotide sequence that is an APRE element of general formula ZXMYKGKAA, wherein Z represents T or G or can also be absent, X represents T or can also be absent, M represents C or A, Y represents C or T and K represents T or G; ii) at least one nucleotide sequence constituting a transcription factor binding site other than the APRE element. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
Specification